Jennifer Schranz
Overview
Jennifer Schranz received $982K in total compensation, including $436K in salary, at Nabriva Therapeutics AG in 2019.
Source: SEC filing on June 25, 2020.
Related executives
We found eight more executives who work or worked at Nabriva Therapeutics AG.
Steven Gelone
Nabriva Therapeutics AG
Chief Operating Officer
Theodore Schroeder
Nabriva Therapeutics AG
Chief Executive Officer
Daniel Dolan
Nabriva Therapeutics AG
Chief Financial Officer
Colin Broom
Nabriva Therapeutics AG
Chief Executive Officer
Francesco Lavino
Nabriva Therapeutics AG
Chief Commercial Officer
Elyse Seltzer
Nabriva Therapeutics AG
Chief Medical Officer
Gary Sender
Nabriva Therapeutics AG
Chief Financial Officer
Peter Wolf
Nabriva Therapeutics AG